Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Thoracic SurgeryAtrial Fibrillation in High Risk Patients
Interventions
DRUG

Amiodarone

DRUG

N-Acetylcysteine

DRUG

Placebo

Trial Locations (9)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester (Consent only), Harrison

11553

Memorial Sloan Kettering Nassau (Consent only), Uniondale

11570

Memorial Sloan Kettering Rockville Centre (Consent only), Rockville Centre

11725

Memorial Sloan Kettering Commack (Consent only), Commack

63110

University of Washington School of Medicine in St. Louis, St Louis

Unknown

Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Consent only), Middletown

07645

Memorial Sloan Kettering Bergen (Consent only), Montvale

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

Vanderbilt University School of Medicine

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER